Burkitt Lymphoma
FDA Approves Rituxan Plus Chemotherapy for Pediatric Hematologic Cancers
The FDA approved rituximab (Rituxan, Genentech) in combination with chemotherapy for pediatric patients (≥6 ...
DECEMBER 8, 2021
Less-Intensive Regimen Posed for Some BL Patients
The findings of an ongoing multicenter study suggest that some patients can experience excellent outcomes with a ...
DECEMBER 20, 2016
Load more